Lifeward (LFWD) EBT Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4,571.00 |
| Dec 31, 2025 | 13,789.00 |
| Sep 30, 2025 | 39,218.00 |
| Jun 30, 2025 | 5,245.00 |
| Mar 31, 2025 | 41,051.00 |
| Dec 31, 2024 | 10,000.00 |
| Sep 30, 2024 | 22,494.00 |
| Jun 30, 2024 | 45,905.00 |
| Mar 31, 2024 | 13,388.00 |
| Dec 31, 2023 | 23,532.00 |
| Sep 30, 2023 | 10,898.00 |
| Jun 30, 2023 | -1,648.00 |
| Mar 31, 2023 | 5,135.00 |
| Dec 31, 2022 | 17,400.00 |
| Sep 30, 2022 | -27,666.00 |
| Jun 30, 2022 | 3,302.00 |
| Mar 31, 2022 | -23,670.00 |
| Dec 31, 2021 | 23,300.00 |
| Sep 30, 2021 | 42,871.00 |
| Jun 30, 2021 | 89,634.00 |
| Mar 31, 2021 | 10,573.00 |
| Dec 31, 2020 | 31,747.00 |
| Sep 30, 2020 | 10,354.00 |
| Jun 30, 2020 | 78,259.00 |
| Mar 31, 2020 | 38,975.00 |
| Dec 31, 2019 | 7,156.00 |
| Sep 30, 2019 | 14,280.00 |
| Dec 31, 2018 | 58,085.00 |
| Sep 30, 2018 | 52,169.00 |